Thus, PDCD11 colocalizes with the C‐MYC oncoprotein in the nucleoplasm of p53‐mutant cancer cells, thereby forming a complex by binding to C‐MYC TAD, which comprises the SKP2‐binding site. Here, TP53 is linked to cancer.